420 related articles for article (PubMed ID: 27726162)
1. Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage.
Rowe AS; Mahbubani PS; Bucklin MH; Clark CT; Hamilton LA
Pharmacotherapy; 2016 Nov; 36(11):1132-1137. PubMed ID: 27726162
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate.
Peksa GD; Mokszycki RK; Rech MA; Maynard B; Panos NG; Sweis RT; DeMott JM
Thromb Haemost; 2020 Feb; 120(2):207-215. PubMed ID: 31837652
[TBL] [Abstract][Full Text] [Related]
3. Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal.
Rowe AS; Dietrich SK; Phillips JW; Foster KE; Canter JR
Crit Care Med; 2018 Jun; 46(6):943-948. PubMed ID: 29498942
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
Hickey M; Gatien M; Taljaard M; Aujnarain A; Giulivi A; Perry JJ
Circulation; 2013 Jul; 128(4):360-4. PubMed ID: 23770745
[TBL] [Abstract][Full Text] [Related]
6. Impact of Obesity on Warfarin Reversal With Fixed-Dose Factor VIII Inhibitor Bypassing Activity (aPCC).
McKinney AL; Dailey LM; McMillen JC; Rowe AS
Ann Pharmacother; 2021 Jul; 55(7):856-862. PubMed ID: 33094635
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
8. Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage.
Carothers C; Giancarelli A; Ibrahim J; Hobbs B
J Surg Res; 2018 Mar; 223():183-187. PubMed ID: 29433872
[TBL] [Abstract][Full Text] [Related]
9. Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study.
Margraf DJ; Seaburg S; Beilman GJ; Wolfson J; Gipson JC; Chapman SA
BMC Emerg Med; 2020 Nov; 20(1):93. PubMed ID: 33243152
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
Huynh TK; Costello JL; Rebuck JA
Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 3-Factor Versus 4-Factor Prothrombin Complex Concentrate With Regard to Warfarin Reversal, Blood Product Use, and Costs.
DeAngelo J; Jarrell D; Cosgrove R; Camamo J; Edwards C; Patanwala AE
Am J Ther; 2018; 25(3):e326-e332. PubMed ID: 28763307
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
Kuroski JE; Young S
Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS
Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592
[TBL] [Abstract][Full Text] [Related]
15. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Sin JH; Berger K; Lesch CA
J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
[TBL] [Abstract][Full Text] [Related]
16. Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal.
Zemrak W; Manuel F; Smith KE; Rolfe S; Hayes T; Trowbridge RL; Carlone B; Seder D
J Thromb Thrombolysis; 2019 Feb; 47(2):263-271. PubMed ID: 30443817
[TBL] [Abstract][Full Text] [Related]
17. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Klein L; Peters J; Miner J; Gorlin J
Am J Emerg Med; 2015 Sep; 33(9):1213-8. PubMed ID: 26143315
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding.
Sheikh-Taha M; Crawley RM
Sci Rep; 2022 Feb; 12(1):1814. PubMed ID: 35110612
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
